Related Experiment Video
Updated: Jun 18, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
The treatment of substance misuse in psychopathic individuals: why heterogeneity matters
Lauren C Gudonis1, Karen Derefinko, Peter R Giancola
1Department of Psychology, University of Kentucky, Lexington, Kentucky, USA.
Abstract:
Psychopathy is a personality syndrome characterized by egocentricity, grandiosity, remorselessness, callousness, impulsivity, and manipulativeness. It is also a disorder highly comorbid with substance use disorders ( Derefinko and Lynam, 2007 ; Smith and Newman, 1990 ; Tourian et al., 1997 ). However, unlike their other criminal counterparts, psychopaths' substance use related problems appear remarkably resilient despite treatment ( Smith and Newman, 1990 ) leading many to conclude the dually diagnosed psychopathic substance misuser is "untreatable." However, this pessimistic stance is predicated upon the notion that psychopathy is a homogeneous, categorical construct. Such a conclusion leaves little hope for treating substance use problems in this population, and has certainly attenuated efforts at developing effective clinical interventions ( Seto and Quinsey, 2006 ). In this review, we argue that conceptualizing psychopathy as a heterogeneous and dimensional construct reveals a common thread of negative emotionality (NEM) that may clarify the relations between psychopathy and substance use disorders as well as pave the way for more practical and viable treatment options.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Drug Therapy
Antianxiety Medications
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Psychosis and Antipsychotic Drugs: Overview
Drug Abuse and Addiction: Pharmacological Phenomena

